Pulmicort and Lymphoma - a phase IV clinical study of FDA data

Summary:

Lymphoma is reported as a side effect among people who take Pulmicort (budesonide), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Nucala, and have Cough.

The phase IV clinical study analyzes which people have Lymphoma when taking Pulmicort. It is created by eHealthMe based on reports of 34,552 people who have side effects when taking Pulmicort from the FDA, and is updated regularly.

What is Pulmicort?

Pulmicort has active ingredients of budesonide. It is often used in asthma. eHealthMe is studying from 34,980 Pulmicort users. Check the latest studies of Pulmicort.

What is Lymphoma?

Lymphoma (cancer that begins in immune system cells) is found to be associated with 961 drugs and 1,015 conditions by eHealthMe. Check the latest studies of Lymphoma.

On Jul, 19, 2026

34,552 people reported to have side effects when taking Pulmicort.
Among them, 39 people (0.11%) have Lymphoma.

Among these 39 people:

How long have people been on Pulmicort when they have Lymphoma? *

What is the gender of people who have Lymphoma when taking Pulmicort? *

female: 84.62 %
male: 15.38 %

What is the age of people who have Lymphoma when taking Pulmicort? *

What are other drugs people take besides Pulmicort? *

What are other side effects people have besides Lymphoma? *

Pneumonia: 21 people, 53.85%
Dyspnea (difficult or laboured breathing): 20 people, 51.28%
Malaise (a feeling of general discomfort or uneasiness): 20 people, 51.28%
Bronchiectasis (abnormal widening of the bronchi or their branches, causing a risk of infection): 20 people, 51.28%
Wheezing (a high-pitched whistling sound made while you breath): 19 people, 48.72%
Rashes (redness): 19 people, 48.72%
Eosinophilic Pneumonia (eosinophil accumulates in the lung): 19 people, 48.72%
Disease Recurrence: 19 people, 48.72%
Lung Disorder (lung disease): 19 people, 48.72%
Microcytic Anaemia (a generic term for any type of anaemia characterized by small red blood cells): 19 people, 48.72%

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 5.13%
Cough: 2 people, 5.13%
Sciatica (a set of symptoms including pain caused by general compression or irritation of one of five spinal nerve roots of each sciatic nerve): 1 person, 2.56%
Respiratory Disorder (respiratory disease): 1 person, 2.56%
Muscle Spasms (muscle contraction): 1 person, 2.56%
Metabolic Disorder (an abnormal function and pattern of body fat. insulin resistance refers to the diminished ability of cells to respond to the action of insulin in promoting the transport of the sugar glucose, from blood into muscles and other tissues): 1 person, 2.56%
Emphysema (chronic respiratory disease - over inflation of the air sacs (alveoli) in the lungs): 1 person, 2.56%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 1 person, 2.56%
Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 1 person, 2.56%
Bipolar Disorder (mood disorder): 1 person, 2.56%

* Approximation only. Some reports may have incomplete information.

Do you take Pulmicort and have Lymphoma?

- Check whether Lymphoma is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Pulmicort:

Pulmicort (34,980 reports)

Lymphoma treatments and more:

Lymphoma (33,395 reports)

Browse all side effects of Pulmicort:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Lymphoma:

Lymphoma (961 drugs)

Browse all the conditions that are associated with Lymphoma:

Lymphoma (1,015 conditions)

Related publications that referenced our studies

Christopher KL, Elner VM, Demirci H, "Conjunctival Lymphoma in a Patient on Fingolimod for Relapsing-Remitting Multiple Sclerosis", Ophthalmic Plastic & Reconstructive Surgery, 2017 May .
Christopher KL, Elner VM, Demirci H, "Conjunctival Lymphoma in a Patient on Fingolimod for Relapsing-Remitting Multiple Sclerosis", Ophthalmic Plastic & Reconstructive Surgery, 2017 May .

How the study uses the data?

The study uses data from the FDA. It is based on budesonide (the active ingredients of Pulmicort) and Pulmicort (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.